COVID-19 now tends to see spikes during cold and flu seasons. Most vaccinated people who contract COVID-19 are not at risk ...
Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache ...
Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...
with the following symptoms commonly reported in connection to COVID-19: Earlier reports had centered on potential gastrointestinal symptoms related to the virus. Dr. Katelyn Jetelina ...
Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.
Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.
Axios Des Moines on MSN22d
Flu cases quadrupled in Washington
If you've been battling the flu, you are not alone. Driving the news: Sick season has arrived in Washington with flu cases ...
With a recent surge in influenza, COVID-19, norovirus, respiratory syncytial virus (RSV), and other respiratory viruses, it's ...
It tends to cause cold-like symptoms, which can make it difficult to tell it apart from other respiratory viruses, such as the flu or COVID-19. The virus isn’t usually a cause of concern in ...
Rand Paul (R-KY) on Monday announced that his committee subpoenaed 14 federal agencies from the exiting Biden-Harris administration in a sweeping investigation into the origins of COVID-19 and U.S ...
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...
The study recruited the first 1,300 patients with neurological symptoms of Long COVID at the Northwestern Medicine Neuro COVID-19 Clinic between May 2020 and March 2023. Of the 1,300 participants ...